Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 1
2021 3
2022 4
2023 6
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.
Bezzio C, Franchellucci G, Savarino EV, Mastronardi M, Caprioli FA, Bodini G, Variola A, Scaldaferri F, Furfaro F, Calabrese E, Principi MB, Biscaglia G, Marzo M, Michielan A, Cavalli C, Aratari A, Campigotto M, Ceccarelli L, Cappello M, Saibeni S, Balestrieri P, Soriano A, Casini V, Bertani L, Barberio B, Conforti FS, Danese S, Armuzzi A. Bezzio C, et al. Among authors: conforti fs. Crohns Colitis 360. 2024 Oct 24;6(4):otae060. doi: 10.1093/crocol/otae060. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39525291 Free PMC article. No abstract available.
An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coli.
Paroni M, Leccese G, Ranzani V, Moschetti G, Chiara M, Perillo F, Ferri S, Clemente F, Noviello D, Conforti FS, Ferrero S, Karnani B, Bosotti R, Vasco C, Curti S, Crosti MC, Gruarin P, Rossetti G, Conte MP, Vecchi M, Pagani M, Landini P, Facciotti F, Abrignani S, Caprioli F, Geginat J. Paroni M, et al. Among authors: conforti fs. J Crohns Colitis. 2023 Dec 30;17(12):1988-2001. doi: 10.1093/ecco-jcc/jjad119. J Crohns Colitis. 2023. PMID: 37462681 Free PMC article.
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study.
Calabrese E, Onali S, Variola A, Ribaldone DG, Savarino EV, Viola A, Saibeni S, Conforti FS, Testa A, Latella G, Orlando A, Principi M, Privitera AC, Guerra M, Ceccarelli L, Mocci G, Boy D, Piccarozzi MA, Gualberti G, Marando F, Gemignani L, D'Amico F. Calabrese E, et al. Among authors: conforti fs. Dig Liver Dis. 2025 Jan;57(1):241-250. doi: 10.1016/j.dld.2024.08.040. Epub 2024 Sep 19. Dig Liver Dis. 2025. PMID: 39299813 Free article.
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC).
Noviello D, Fries W, Orlando A, Conforti FS, Bezzio C, Castiglione F, Fantini MC, Savarino EV, Festa S, Ribaldone DG, Mocci G, Grossi L, Viganò C, Imperatore N, Ceccarelli L, Gabrielli AMC, Scardino G, Saibeni S, Balestrieri P, Principi M, Campigotto M, Gravina AG, Spagnuolo R, Scaldaferri F, Neri B, Sario AD, Baldoni M, Mitri RD, Tettoni E, Calderone S, Armuzzi A, Macaluso FS, Vecchi M, Ventimiglia M, Caprioli F; VE2TO-UC study group. Noviello D, et al. Among authors: conforti fs. Dig Liver Dis. 2025 Jul;57(7):1419-1427. doi: 10.1016/j.dld.2025.04.025. Epub 2025 May 6. Dig Liver Dis. 2025. PMID: 40335332
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.
Costantino A, Noviello D, Conforti FS, Aloi M, Armuzzi A, Bossa F, Ficari F, Leone S, Manguso F, Mocci G, Orlando A, Pironi L, Radice S, Rizzello F, Tongiorgi A, Costantino C, Vecchi M, Caprioli F. Costantino A, et al. Among authors: conforti fs. Inflamm Bowel Dis. 2022 Mar 2;28(3):474-478. doi: 10.1093/ibd/izab172. Inflamm Bowel Dis. 2022. PMID: 34259844 Free PMC article. No abstract available.
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD).
Principi M, Macaluso FS, Todeschini A, Facciotti F, Contaldo A, Castiglione F, Nardone OM, Spagnuolo R, Doldo P, Riguccio G, Conforti FS, Viganò C, Ascolani M, Fiorino G, Correale C, Bodini G, Milla M, Scardino G, Vernero M, Desideri F, Caprioli F, Mannino M, Rizzo G, Orlando A; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Principi M, et al. Among authors: conforti fs. Eur J Gastroenterol Hepatol. 2023 Jun 1;35(6):629-634. doi: 10.1097/MEG.0000000000002550. Epub 2023 Apr 4. Eur J Gastroenterol Hepatol. 2023. PMID: 37115976
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.
Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F. Mazza S, et al. Among authors: conforti fs. Clin Transl Sci. 2022 Jan;15(1):172-181. doi: 10.1111/cts.13131. Epub 2021 Sep 15. Clin Transl Sci. 2022. PMID: 34523800 Free PMC article.
17 results